Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 361 - 380 of 1970 results

Herpes Zoster Vaccination Among Medicare Beneficiaries With and Without Prescription Drug Coverage.

Tsai, Yuping ;

Leung, Jessica

January 2025 | Vaccine, 2025, v. 43, no. 1

The Inflation Reduction Act (IRA) eliminated cost sharing for Medicare Part D-covered vaccines but did not address the cost burden faced by Medicare beneficiaries who did not have prescription drug coverage. This study aimed to determine the characteristics of beneficiaries without prescription drug coverage and to assess the association between th ...

10/09/2026

Supporting Files

Title : Herpes Zoster Vaccination Among Medicare Beneficiaries With and Without Prescription Drug Coverage. Personal Author(s) : Tsai, Yuping;Leung, Jessica;Anderson, Tara C.;Zhou, Fangjun;Singleton, James A.; Published Date : January 2025 Pages in Document : 126537 (15 pdf pages) Source : Vaccine, 2025, v. 43, no. 1 DOI : https://doi.org/10.1016/j.vaccine.2024.126537 Journal Title : Vaccine
Tsai, Y., Leung, J., Anderson, T. C., Zhou, F., & Singleton, J. A. (2025). Herpes Zoster Vaccination Among Medicare Beneficiaries With and Without Prescription Drug Coverage. Vaccine, 43(1). https://doi.org/10.1016/j.vaccine.2024.126537

Tsai, Yuping, Jessica Leung, Tara C. Anderson, Fangjun Zhou, and James A. Singleton. "Herpes Zoster Vaccination Among Medicare Beneficiaries With and Without Prescription Drug Coverage." Vaccine 43, no. 1 (2025). https://doi.org/10.1016/j.vaccine.2024.126537.

Tsai, Yuping, et al. "Herpes Zoster Vaccination Among Medicare Beneficiaries With and Without Prescription Drug Coverage." Vaccine, vol. 43, no. 1, 2025. Stacks. https://doi.org/10.1016/j.vaccine.2024.126537.
Export RIS Citation Information. TY - Journal Article AU - Tsai, Yuping AU - Leung, Jessica AU - Anderson, Tara C. AU - Zhou, Fangjun AU - Singleton, James A. AB - The Inflation Reduction Act (IRA) eliminated cost sharing for Medicare Part D-covered vaccines but did not address the cost burden faced by Medicare beneficiaries who did not have prescription drug coverage. This study aimed to determine the characteristics of beneficiaries without prescription drug coverage and to assess the association between the receipt of a herpes zoster vaccine and prescription drug coverage status. AB - We used the 2019-2023 National Health Interview Survey and included Medicare beneficiaries aged 65 years and older who enrolled in both Parts A and B or a Medicare Advantage plan. Descriptive statistics were used to examine beneficiaries' characteristics. Logistic regressions were used to examine the associations between the receipt of a herpes zoster vaccine and Medicare prescription drug coverage. AB - The study included 33,578 beneficiaries and 93.5 % of beneficiaries had prescription drug coverage. The prevalence of lacking prescription drug coverage was higher among beneficiaries who did not have a college degree, had family income below the poverty level, had no flu shot and well visit within the past year, and had no usual place for care. The probability of receiving a herpes zoster vaccine was higher among beneficiaries with prescription drug coverage than those without prescription coverage (45.2 % versus 25.3 %). AB - Herpes zoster vaccination disparities between beneficiaries with and without prescription drug coverage existed before the IRA. Because the IRA only addresses the cost barrier facing by beneficiaries with prescription drug coverage, vaccination disparities was greater after the IRA implementation. AB - Author manuscript AN - cdc:261906 C4 - PMC11878214 DO - https://doi.org/10.1016/j.vaccine.2024.126537 IS - 1 J2 - Vaccine KW - Medicare KW - Medicare Part D KW - Herpes Zoster Vaccine KW - Aged, 80 and over KW - Insurance Coverage KW - Female KW - Vaccination KW - Aged KW - Male KW - Humans KW - Herpes Zoster KW - Prescription Drugs KW - Medicare KW - Immunization KW - Inflation reduction act KW - Herpes zoster vaccine KW - Older adults KW - Humans KW - Aged KW - Male KW - Female KW - Herpes Zoster Vaccine KW - Herpes Zoster KW - Aged, 80 and over KW - Vaccination KW - Medicare KW - Medicare Part D KW - Prescription Drugs KW - Insurance Coverage LA - eng PY - 2025 T2 - Vaccine T2 - Vaccine, 2025, v. 43, no. 1 TI - Herpes Zoster Vaccination Among Medicare Beneficiaries With and Without Prescription Drug Coverage. VL - 43 UR - https://stacks.cdc.gov/view/cdc/261906 ER -
Concordance of Traumatic Brain Injury Symptoms, Evaluation, and Diagnosis Between Teens and Parents: Data From the National Health Interview Survey-Teen.

Black, Lindsey I. ;

Ng, Amanda E.

March 2025 | The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 2025, v. 76, no. 3

To investigate differences in teen-reported and parent-reported lifetime prevalence estimates of traumatic brain injury (TBI) symptoms, TBI evaluation, and TBI diagnosis among a nationally representative sample of teenagers aged 12-17 years old and their parents.Parent-reported data from the 2021 to 2022 National Health Interview Survey linked with ...

10/09/2026

Supporting Files

Title : Concordance of Traumatic Brain Injury Symptoms, Evaluation, and Diagnosis Between Teens and Parents: Data From the National Health Interview Survey-Teen. Personal Author(s) : Black, Lindsey I.;Ng, Amanda E.;Zablotsky, Benjamin;Peterson, Alexis;Daugherty, Jill;Waltzman, Dana;Bose, Jonaki; Published Date : March 2025 Pages in Document : 441-447 (17 pdf pages) Source : The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 2025, v. 76, no. 3 DOI : https://doi.org/10.1016/j.jadohealth.2024.10.018 Journal Title : The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine
Black, L. I., Ng, A. E., Zablotsky, B., Peterson, A., Daugherty, J., Waltzman, D., & Bose, J. (2025). Concordance of Traumatic Brain Injury Symptoms, Evaluation, and Diagnosis Between Teens and Parents: Data From the National Health Interview Survey-Teen. The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 76(3). https://doi.org/10.1016/j.jadohealth.2024.10.018

Black, Lindsey I., Amanda E. Ng, Benjamin Zablotsky, Alexis Peterson, Jill Daugherty, Dana Waltzman, and Jonaki Bose. "Concordance of Traumatic Brain Injury Symptoms, Evaluation, and Diagnosis Between Teens and Parents: Data From the National Health Interview Survey-Teen." The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 76, no. 3 (2025). https://doi.org/10.1016/j.jadohealth.2024.10.018.

Black, Lindsey I., et al. "Concordance of Traumatic Brain Injury Symptoms, Evaluation, and Diagnosis Between Teens and Parents: Data From the National Health Interview Survey-Teen." The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, vol. 76, no. 3, 2025. Stacks. https://doi.org/10.1016/j.jadohealth.2024.10.018.
Export RIS Citation Information. TY - Journal Article AU - Black, Lindsey I. AU - Ng, Amanda E. AU - Zablotsky, Benjamin AU - Peterson, Alexis AU - Daugherty, Jill AU - Waltzman, Dana AU - Bose, Jonaki AB - To investigate differences in teen-reported and parent-reported lifetime prevalence estimates of traumatic brain injury (TBI) symptoms, TBI evaluation, and TBI diagnosis among a nationally representative sample of teenagers aged 12-17 years old and their parents. AB - Parent-reported data from the 2021 to 2022 National Health Interview Survey linked with teen-reported data from the National Health Interview Survey-Teen July 2021-December 2022 (n = 1,153) were analyzed. Lifetime prevalence estimates for TBI symptoms (e.g., selected symptoms as a result of a blow or jolt to the head), history of evaluation by health professional for TBI (i.e., TBI evaluation), and TBI diagnosis stratified by sociodemographic characteristics and reporter type were produced, and z-tests were conducted to test for differences. Concordance measures were calculated to assess agreement between teen and parent survey responses to TBI measures. AB - Lifetime prevalence of TBI symptoms varied by reporter type across all sociodemographic characteristics with teen-report consistently producing higher estimates. Estimates of TBI evaluation varied by reporter type only among older teens, non-Hispanic teens, and teens who participated in sports; there was no difference for TBI diagnosis. Percent agreement between the 2 reporters ranged from 73% to 95%, prevalence-adjusted bias-adjusted kappa ranged from 0.45 to 0.90, and Cohen's kappa ranged from 0.22 to 0.63. AB - There was general agreement for observable outcomes TBI evaluation and TBI diagnosis, but discordance existed in reports of TBI symptoms. These findings suggest that youth self-report of TBI symptoms may enhance surveillance efforts. AB - Author manuscript AN - cdc:261905 C4 - PMC11830522 DO - https://doi.org/10.1016/j.jadohealth.2024.10.018 IS - 3 J2 - The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine KW - Child KW - Adolescent KW - Female KW - Prevalence KW - Parents KW - Male KW - Humans KW - Health Surveys KW - Brain Injuries, Traumatic KW - Adolescents KW - head injuries KW - concussions KW - surveys KW - surveillance KW - National Health Interview Survey-Teen KW - National Health Interview Survey KW - Humans KW - Adolescent KW - Brain Injuries, Traumatic KW - Male KW - Female KW - Parents KW - Child KW - Prevalence KW - Health Surveys LA - eng PY - 2025 T2 - The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine T2 - The Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine, 2025, v. 76, no. 3 TI - Concordance of Traumatic Brain Injury Symptoms, Evaluation, and Diagnosis Between Teens and Parents: Data From the National Health Interview Survey-Teen. VL - 76 UR - https://stacks.cdc.gov/view/cdc/261905 ER -
Poor Vaccine Responders Mask the True Trend in Vaccine Effectiveness Against Progression to Severe Disease.

Dean, Natalie E. ;

Halloran, M. Elizabeth

January 2025 | Vaccine, 2025, v. 43, no. 2

Vaccines can reduce an individual's risk of infection and their risk of progression to severe disease given infection. The latter effect is less commonly estimated but is relevant for vaccine impact modeling and cost-effectiveness calculations. Using a motivating example from the COVID-19 literature, we note how vaccine effectiveness against progre ...

10/09/2026

Supporting Files

Title : Poor Vaccine Responders Mask the True Trend in Vaccine Effectiveness Against Progression to Severe Disease. Personal Author(s) : Dean, Natalie E.;Halloran, M. Elizabeth;Zarnitsyna, Veronika I.; Published Date : January 2025 Pages in Document : 126516 (18 pdf pages) Source : Vaccine, 2025, v. 43, no. 2 DOI : https://doi.org/10.1016/j.vaccine.2024.126516 Journal Title : Vaccine
Dean, N. E., Halloran, M. E., & Zarnitsyna, V. I. (2025). Poor Vaccine Responders Mask the True Trend in Vaccine Effectiveness Against Progression to Severe Disease. Vaccine, 43(2). https://doi.org/10.1016/j.vaccine.2024.126516

Dean, Natalie E., M. Elizabeth Halloran, and Veronika I. Zarnitsyna. "Poor Vaccine Responders Mask the True Trend in Vaccine Effectiveness Against Progression to Severe Disease." Vaccine 43, no. 2 (2025). https://doi.org/10.1016/j.vaccine.2024.126516.

Dean, Natalie E., et al. "Poor Vaccine Responders Mask the True Trend in Vaccine Effectiveness Against Progression to Severe Disease." Vaccine, vol. 43, no. 2, 2025. Stacks. https://doi.org/10.1016/j.vaccine.2024.126516.
Export RIS Citation Information. TY - Journal Article AU - Dean, Natalie E. AU - Halloran, M. Elizabeth AU - Zarnitsyna, Veronika I. AB - Vaccines can reduce an individual's risk of infection and their risk of progression to severe disease given infection. The latter effect is less commonly estimated but is relevant for vaccine impact modeling and cost-effectiveness calculations. Using a motivating example from the COVID-19 literature, we note how vaccine effectiveness against progression to severe disease can appear to increase from below 0 % to over 70 % within 8 months. With true biological strengthening of this magnitude being unlikely, we use a mathematical modeling framework to identify parameter combinations where this phenomenon can occur. Fundamental features are an immunocompetent population with high initial protection against infection, contrasted with a vulnerable subpopulation with poor vaccine response against infection and progression. As a result, the earliest infections are among those with the weakest protection against severe disease. This work highlights methodological challenges in isolating a vaccine's effect on progression to severe disease after infection, and it signals the need for refined analytical methods to adjust for differences between the vaccinated infected and the unvaccinated infected populations. AB - Author manuscript AN - cdc:261904 C4 - PMC11822770 DO - https://doi.org/10.1016/j.vaccine.2024.126516 IS - 2 J2 - Vaccine KW - Models, Theoretical KW - Vaccination KW - COVID-19 Vaccines KW - Vaccine Efficacy KW - SARS-CoV-2 KW - Humans KW - COVID-19 KW - Disease Progression KW - Vaccine waning KW - protection against infection KW - progression to severe disease KW - Humans KW - COVID-19 KW - Disease Progression KW - COVID-19 Vaccines KW - SARS-CoV-2 KW - Vaccine Efficacy KW - Models, Theoretical KW - Vaccination LA - eng PY - 2025 T2 - Vaccine T2 - Vaccine, 2025, v. 43, no. 2 TI - Poor Vaccine Responders Mask the True Trend in Vaccine Effectiveness Against Progression to Severe Disease. VL - 43 UR - https://stacks.cdc.gov/view/cdc/261904 ER -
The Spectrum of Cutaneous Granulomatous Inflammation and Detection of Rubella Virus in Skin Biopsies of Patients With Common Variable Immune Deficiency.

King, Anne L. ;

Johnson, Emma F.

March 2025 | Journal of Cutaneous Pathology, 2025, v. 52, no. 3

There is a known association between common variable immunodeficiency (CVID) and granulomas in multiple organ systems, including the skin, lung, liver, and spleen. Rubella virus has also been detected within cutaneous granulomas in both immunocompetent and immunocompromised hosts. We present a retrospective case series of patients with CVID and gra ...

10/09/2026

Supporting Files

Title : The Spectrum of Cutaneous Granulomatous Inflammation and Detection of Rubella Virus in Skin Biopsies of Patients With Common Variable Immune Deficiency. Personal Author(s) : King, Anne L.;Johnson, Emma F.;Alavi, Afsaneh;Agrawal, Shruti;Sokumbi, Olayemi;Perelygina, Ludmila;Yorke, Laura;Beard, Suzanne;Wieland, Carilyn N.; Published Date : March 2025 Pages in Document : 220-226 (15 pdf pages) Source : Journal of Cutaneous Pathology, 2025, v. 52, no. 3 DOI : https://doi.org/10.1111/cup.14761 Journal Title : Journal of Cutaneous Pathology
King, A. L., Johnson, E. F., Alavi, A., Agrawal, S., Sokumbi, O., Perelygina, L., Yorke, L., Beard, S., & Wieland, C. N. (2025). The Spectrum of Cutaneous Granulomatous Inflammation and Detection of Rubella Virus in Skin Biopsies of Patients With Common Variable Immune Deficiency. Journal of Cutaneous Pathology, 52(3). https://doi.org/10.1111/cup.14761

King, Anne L., Emma F. Johnson, Afsaneh Alavi, Shruti Agrawal, Olayemi Sokumbi, Ludmila Perelygina, Laura Yorke, Suzanne Beard, and Carilyn N. Wieland. "The Spectrum of Cutaneous Granulomatous Inflammation and Detection of Rubella Virus in Skin Biopsies of Patients With Common Variable Immune Deficiency." Journal of Cutaneous Pathology 52, no. 3 (2025). https://doi.org/10.1111/cup.14761.

King, Anne L., et al. "The Spectrum of Cutaneous Granulomatous Inflammation and Detection of Rubella Virus in Skin Biopsies of Patients With Common Variable Immune Deficiency." Journal of Cutaneous Pathology, vol. 52, no. 3, 2025. Stacks. https://doi.org/10.1111/cup.14761.
Export RIS Citation Information. TY - Journal Article AU - King, Anne L. AU - Johnson, Emma F. AU - Alavi, Afsaneh AU - Agrawal, Shruti AU - Sokumbi, Olayemi AU - Perelygina, Ludmila AU - Yorke, Laura AU - Beard, Suzanne AU - Wieland, Carilyn N. AB - There is a known association between common variable immunodeficiency (CVID) and granulomas in multiple organ systems, including the skin, lung, liver, and spleen. Rubella virus has also been detected within cutaneous granulomas in both immunocompetent and immunocompromised hosts. We present a retrospective case series of patients with CVID and granulomatous skin disease and describe the spectrum of clinical and histopathologic features, including the status of rubella virus in the cutaneous granulomas. AB - We retrospectively reviewed the clinical and histopathological characteristics of patients diagnosed with CVID at our institution, with cutaneous findings and skin biopsies available for review between 1990 and 2023, demonstrating granulomatous inflammation. AB - Eight patients met the inclusion criteria. The most common histopathologic pattern was palisaded granulomatous inflammation, seen in five of eight cases. Three cases showed strictly sarcoidal granulomas. Background inflammation was peri-granulomatous (8/8) and the predominant background inflammatory cell type was lymphocytic (6/8). Rubella virus testing was performed for seven of eight cases and found to be positive in one case. AB - Cutaneous granulomatous disease in CVID can present with a spectrum of clinical morphologies, granulomatous patterns, and variable rubella virus persistence. Dermatopathologists should be aware of the spectrum of findings when considering cutaneous CVID-related granulomatous disease in the differential diagnosis. AB - Author manuscript AN - cdc:261903 C4 - PMC11949121 DO - https://doi.org/10.1111/cup.14761 IS - 3 J2 - Journal of Cutaneous Pathology KW - Female KW - Rubella virus KW - Inflammation KW - Young Adult KW - Biopsy KW - Retrospective Studies KW - Skin KW - Rubella KW - Skin Diseases KW - Male KW - Humans KW - Middle Aged KW - Adult KW - Common Variable Immunodeficiency KW - Granuloma KW - chronic variable immune deficiency KW - cutaneous granulomas KW - dermatopathology KW - granulomatous dermatitis KW - rubella virus KW - Humans KW - Granuloma KW - Female KW - Male KW - Rubella virus KW - Retrospective Studies KW - Common Variable Immunodeficiency KW - Adult KW - Middle Aged KW - Biopsy KW - Skin KW - Inflammation KW - Rubella KW - Skin Diseases KW - Young Adult LA - eng PY - 2025 T2 - Journal of Cutaneous Pathology T2 - Journal of Cutaneous Pathology, 2025, v. 52, no. 3 TI - The Spectrum of Cutaneous Granulomatous Inflammation and Detection of Rubella Virus in Skin Biopsies of Patients With Common Variable Immune Deficiency. VL - 52 UR - https://stacks.cdc.gov/view/cdc/261903 ER -
Challenges and Opportunities For Treating Hepatitis C Amongst People Who Use Drugs: Experience of An Integrated Mobile Clinic in Baltimore City.

Rosecrans, Amanda ;

Harris, Robert

April 2025 | Journal of Viral Hepatitis, 2025, v. 32, no. 4

Progress in treating chronic hepatitis C virus (HCV) infection has been slow amongst people who use drugs (PWUD). This study describes the HCV treatment cascade amongst people accessing a mobile clinic offering integrated low-threshold buprenorphine and infectious disease services in Baltimore City. From May 1, 2021, to December 31, 2022, 560 peopl ...

10/09/2026

Supporting Files

Title : Challenges and Opportunities For Treating Hepatitis C Amongst People Who Use Drugs: Experience of An Integrated Mobile Clinic in Baltimore City. Personal Author(s) : Rosecrans, Amanda;Harris, Robert;St Clair, Anne;Rice, Molly;Zoltick, Meredith;Willman, Catherine;King, Anne;Kerr, Meredith;Page, Kathleen R.; Published Date : April 2025 Pages in Document : e14038 (7 pdf pages) Source : Journal of Viral Hepatitis, 2025, v. 32, no. 4 DOI : https://doi.org/10.1111/jvh.14038 Journal Title : Journal of Viral Hepatitis
Rosecrans, A., Harris, R., St Clair, A., Rice, M., Zoltick, M., Willman, C., King, A., Kerr, M., & Page, K. R. (2025). Challenges and Opportunities For Treating Hepatitis C Amongst People Who Use Drugs: Experience of An Integrated Mobile Clinic in Baltimore City. Journal of Viral Hepatitis, 32(4). https://doi.org/10.1111/jvh.14038

Rosecrans, Amanda, Robert Harris, Anne St Clair, Molly Rice, Meredith Zoltick, Catherine Willman, Anne King, Meredith Kerr, and Kathleen R. Page. "Challenges and Opportunities For Treating Hepatitis C Amongst People Who Use Drugs: Experience of An Integrated Mobile Clinic in Baltimore City." Journal of Viral Hepatitis 32, no. 4 (2025). https://doi.org/10.1111/jvh.14038.

Rosecrans, Amanda, et al. "Challenges and Opportunities For Treating Hepatitis C Amongst People Who Use Drugs: Experience of An Integrated Mobile Clinic in Baltimore City." Journal of Viral Hepatitis, vol. 32, no. 4, 2025. Stacks. https://doi.org/10.1111/jvh.14038.
Export RIS Citation Information. TY - Journal Article AU - Rosecrans, Amanda AU - Harris, Robert AU - St Clair, Anne AU - Rice, Molly AU - Zoltick, Meredith AU - Willman, Catherine AU - King, Anne AU - Kerr, Meredith AU - Page, Kathleen R. AB - Progress in treating chronic hepatitis C virus (HCV) infection has been slow amongst people who use drugs (PWUD). This study describes the HCV treatment cascade amongst people accessing a mobile clinic offering integrated low-threshold buprenorphine and infectious disease services in Baltimore City. From May 1, 2021, to December 31, 2022, 560 people had a rapid HCV antibody test, of whom 201 (36%) had a positive result and amongst those, 117 (58%) had an HCV RNA test performed, 81 (40%) had a documented positive RNA, 45 (22%) were prescribed medication, 42 (21%) started medication, 32 (16%) completed medication, 22 (11%) had blood work to assess for sustained virologic response and 20 (10%) had a documented cure. Challenges including housing instability, insurance barriers and lack of venous access limit progress in this cascade. Providing integrated care models to meet the needs of PWUD in the community is necessary but not sufficient to make progress in improving HCV treatment. Removal of insurance restrictions, availability of point-of-care HCV RNA testing, development of rapid HCV treatment guidelines and development of long-acting injectable HCV treatment are needed to move towards a same-day, one-time test and treat model of care. AB - Author manuscript AN - cdc:261902 C4 - PMC13249361 DO - https://doi.org/10.1111/jvh.14038 IS - 4 J2 - Journal of Viral Hepatitis KW - Antiviral Agents KW - Female KW - RNA, Viral KW - Hepatitis C, Chronic KW - Mobile Health Units KW - Drug Users KW - Male KW - Middle Aged KW - Humans KW - Sustained Virologic Response KW - Adult KW - Substance Abuse, Intravenous KW - Hepacivirus KW - hepatitis C treatment KW - homeless KW - mobile clinic KW - people who use drugs KW - Humans KW - Male KW - Female KW - Adult KW - Antiviral Agents KW - Hepatitis C, Chronic KW - Middle Aged KW - Mobile Health Units KW - Substance Abuse, Intravenous KW - Drug Users KW - RNA, Viral KW - Hepacivirus KW - Sustained Virologic Response LA - eng PY - 2025 T2 - Journal of Viral Hepatitis T2 - Journal of Viral Hepatitis, 2025, v. 32, no. 4 TI - Challenges and Opportunities For Treating Hepatitis C Amongst People Who Use Drugs: Experience of An Integrated Mobile Clinic in Baltimore City. VL - 32 UR - https://stacks.cdc.gov/view/cdc/261902 ER -
Making Safety an Easy Catch: PFD Use Among Commercial Fishermen in New England.

Milkovich, Pamela J. ;

Roome, Amanda B.

April 2025 | Journal of Agromedicine, 2025, v. 30, no. 2

This brief highlights the development and administration of Lifejackets for Lobstermen and its successor, Lifejackets for Fishermen. These programs provide education about, physical access to, and monetary incentives for personal floatation devices (PFDs). Preliminary data shows that commercial fishermen in New England have increased their PFD wear ...

10/09/2026

Supporting Files

Title : Making Safety an Easy Catch: PFD Use Among Commercial Fishermen in New England. Personal Author(s) : Milkovich, Pamela J.;Roome, Amanda B.;Orchard, Daniel;Sorensen, Julie A.; Published Date : April 2025 Pages in Document : 210-213 (5 pdf pages) Source : Journal of Agromedicine, 2025, v. 30, no. 2 DOI : https://doi.org/10.1080/1059924X.2024.2433244 Journal Title : Journal of Agromedicine
Milkovich, P. J., Roome, A. B., Orchard, D., & Sorensen, J. A. (2025). Making Safety an Easy Catch: PFD Use Among Commercial Fishermen in New England. Journal of Agromedicine, 30(2). https://doi.org/10.1080/1059924X.2024.2433244

Milkovich, Pamela J., Amanda B. Roome, Daniel Orchard, and Julie A. Sorensen. "Making Safety an Easy Catch: PFD Use Among Commercial Fishermen in New England." Journal of Agromedicine 30, no. 2 (2025). https://doi.org/10.1080/1059924X.2024.2433244.

Milkovich, Pamela J., et al. "Making Safety an Easy Catch: PFD Use Among Commercial Fishermen in New England." Journal of Agromedicine, vol. 30, no. 2, 2025. Stacks. https://doi.org/10.1080/1059924X.2024.2433244.
Export RIS Citation Information. TY - Journal Article AU - Milkovich, Pamela J. AU - Roome, Amanda B. AU - Orchard, Daniel AU - Sorensen, Julie A. AB - This brief highlights the development and administration of Lifejackets for Lobstermen and its successor, Lifejackets for Fishermen. These programs provide education about, physical access to, and monetary incentives for personal floatation devices (PFDs). Preliminary data shows that commercial fishermen in New England have increased their PFD wear rates significantly since the launch of these programs in 2019. AB - Author manuscript AN - cdc:261901 C4 - PMC13036583 DO - https://doi.org/10.1080/1059924X.2024.2433244 IS - 2 J2 - Journal of Agromedicine KW - Humans KW - Personal Protective Equipment KW - Occupational Health KW - Fisheries KW - Lifejackets KW - falls overboard KW - behavior change KW - Humans KW - Fisheries KW - Occupational Health KW - Personal Protective Equipment LA - eng PY - 2025 T2 - Journal of Agromedicine T2 - Journal of Agromedicine, 2025, v. 30, no. 2 TI - Making Safety an Easy Catch: PFD Use Among Commercial Fishermen in New England. VL - 30 UR - https://stacks.cdc.gov/view/cdc/261901 ER -
Homeless Encampments and Involuntary Displacement.

Meehan, Ashley A. ;

Hagan, Liesl M.

March 11, 2025 | JAMA, 2025, v. 333, no. 10

In 2023, more than 653 000 people experienced homelessness in the US on any given night, the most since counting began in 2007.1 Research has consistently shown that homelessness leads to poor health.2,3 Staying in congregate homeless shelters increases risk of infectious diseases like einfluenza,COVID-19, and tuberculosis, whereas living outside i ...

10/09/2026

Supporting Files

Title : Homeless Encampments and Involuntary Displacement. Personal Author(s) : Meehan, Ashley A.;Hagan, Liesl M.;Butler, Jay C.; Published Date : March 11, 2025 Pages in Document : 845-846 (5 pdf pages) Source : JAMA, 2025, v. 333, no. 10 DOI : https://doi.org/10.1001/jama.2024.22989 Journal Title : JAMA
Meehan, A. A., Hagan, L. M., & Butler, J. C. (2025). Homeless Encampments and Involuntary Displacement. JAMA, 333(10). https://doi.org/10.1001/jama.2024.22989

Meehan, Ashley A., Liesl M. Hagan, and Jay C. Butler. "Homeless Encampments and Involuntary Displacement." JAMA 333, no. 10 (2025). https://doi.org/10.1001/jama.2024.22989.

Meehan, Ashley A., et al. "Homeless Encampments and Involuntary Displacement." JAMA, vol. 333, no. 10, 2025. Stacks. https://doi.org/10.1001/jama.2024.22989.
Export RIS Citation Information. TY - Journal Article AU - Meehan, Ashley A. AU - Hagan, Liesl M. AU - Butler, Jay C. AB - In 2023, more than 653 000 people experienced homelessness in the US on any given night, the most since counting began in 2007.1 Research has consistently shown that homelessness leads to poor health.2,3 Staying in congregate homeless shelters increases risk of infectious diseases like einfluenza,COVID-19, and tuberculosis, whereas living outside increases risk of motor vehicle-pedestrian injuries, sanitation-related concerns, and elemental exposures.2,4 Challenges accessing health care while unhoused complicates management of conditions like diabetes, heart disease, HIV, substance use disorders, and mental illness.5,6 People commonly cycle between sheltered and unsheltered settings, thus face the health threats of both. AB - Author manuscript AN - cdc:261900 C4 - PMC11903157 DO - https://doi.org/10.1001/jama.2024.22989 IS - 10 J2 - JAMA KW - Delivery of Health Care KW - Sanitation KW - Pedestrians KW - Ill-Housed Persons KW - Substance-Related Disorders KW - Communicable Diseases KW - Pedestrians KW - Sanitation KW - Substance-Related Disorders KW - Communicable Diseases KW - Ill-Housed Persons KW - Delivery of Health Care LA - eng PY - 2025 T2 - JAMA T2 - JAMA, 2025, v. 333, no. 10 TI - Homeless Encampments and Involuntary Displacement. VL - 333 UR - https://stacks.cdc.gov/view/cdc/261900 ER -
Using Double-negative Controls to Adjust For Healthy-user Bias in a Recombinant Zoster Vaccine Safety Study.

Li, Kendrick ;

Emerman, Iris

Sep-03-2025 | American Journal of Epidemiology, Sep-03-2025, v. 194, no. 9

Unmeasured confounding is a major concern in many epidemiologic studies that are not randomized. Negative control methods can detect and reduce confounding by leveraging the proxies of the unmeasured confounders, including negative control outcomes (NCOs) and exposures (NCEs). An NCO is presumably unaffected by the exposure of interest but would be ...

10/09/2026

Supporting Files

Title : Using Double-negative Controls to Adjust For Healthy-user Bias in a Recombinant Zoster Vaccine Safety Study. Personal Author(s) : Li, Kendrick;Emerman, Iris;Cook, Andrea J.;Fireman, Bruce H.;Sundaram, Maria;Tseng, Hung-Fu X.;Weintraub, Eric S.;Yu, Onchee;Nelson, Jennifer L.;Shi, Xu; Published Date : Sep-03-2025 Pages in Document : 2641-2649 (19 pdf pages) Source : American Journal of Epidemiology, Sep-03-2025, v. 194, no. 9 DOI : https://doi.org/10.1093/aje/kwae439 Journal Title : American Journal of Epidemiology
Li, K., Emerman, I., Cook, A. J., Fireman, B. H., Sundaram, M., Tseng, H. F. X., Weintraub, E. S., Yu, O., Nelson, J. L., & Shi, X. (2025). Using Double-negative Controls to Adjust For Healthy-user Bias in a Recombinant Zoster Vaccine Safety Study. American Journal of Epidemiology, 194(9). https://doi.org/10.1093/aje/kwae439

Li, Kendrick, Iris Emerman, Andrea J. Cook, Bruce H. Fireman, Maria Sundaram, Hung-Fu X. Tseng, Eric S. Weintraub, Onchee Yu, Jennifer L. Nelson, and Xu Shi. "Using Double-negative Controls to Adjust For Healthy-user Bias in a Recombinant Zoster Vaccine Safety Study." American Journal of Epidemiology 194, no. 9 (2025). https://doi.org/10.1093/aje/kwae439.

Li, Kendrick, et al. "Using Double-negative Controls to Adjust For Healthy-user Bias in a Recombinant Zoster Vaccine Safety Study." American Journal of Epidemiology, vol. 194, no. 9, 2025. Stacks. https://doi.org/10.1093/aje/kwae439.
Export RIS Citation Information. TY - Journal Article AU - Li, Kendrick AU - Emerman, Iris AU - Cook, Andrea J. AU - Fireman, Bruce H. AU - Sundaram, Maria AU - Tseng, Hung-Fu X. AU - Weintraub, Eric S. AU - Yu, Onchee AU - Nelson, Jennifer L. AU - Shi, Xu AB - Unmeasured confounding is a major concern in many epidemiologic studies that are not randomized. Negative control methods can detect and reduce confounding by leveraging the proxies of the unmeasured confounders, including negative control outcomes (NCOs) and exposures (NCEs). An NCO is presumably unaffected by the exposure of interest but would be associated with unmeasured confounders; an NCE presumably does not affect the outcome of interest but would be associated with unmeasured confounders. A recently proposed double-negative control method leverages both NCOs and NCEs for unmeasured confounding bias. To demonstrate this relatively new methodology in pharmacoepidemiologic studies, we reanalyzed data from a prior safety study of recombinant zoster vaccine (RZV). The prior study compared risk of safety outcomes of individuals who received the RZV with those of unvaccinated comparators, using logistic regression with propensity score adjustment. We identified NCOs and NCEs that could be used to adjust for unmeasured confounding bias that could arise if RZV recipients are incomparable to the comparators due to unmeasured factors. The double-negative control analysis yielded relative risk estimates slightly closer to 1.0 than those reported previously, providing additional evidence of RZV safety that is less vulnerable to unmeasured confounding. AB - Author manuscript AN - cdc:261899 C4 - PMC12104472 DO - https://doi.org/10.1093/aje/kwae439 IS - 9 J2 - American Journal of Epidemiology KW - Female KW - Aged KW - Logistic Models KW - Propensity Score KW - Herpes Zoster Vaccine KW - Vaccines, Synthetic KW - Bias KW - Pharmacoepidemiology KW - Male KW - Humans KW - Middle Aged KW - Herpes Zoster KW - Confounding Factors, Epidemiologic KW - Vaccine safety monitoring KW - proximal causal inference KW - unmeasured confounding KW - vaccine effectiveness KW - Humans KW - Herpes Zoster Vaccine KW - Bias KW - Confounding Factors, Epidemiologic KW - Vaccines, Synthetic KW - Herpes Zoster KW - Female KW - Male KW - Propensity Score KW - Logistic Models KW - Aged KW - Middle Aged KW - Pharmacoepidemiology LA - eng PY - 2025 T2 - American Journal of Epidemiology T2 - American Journal of Epidemiology, Sep-03-2025, v. 194, no. 9 TI - Using Double-negative Controls to Adjust For Healthy-user Bias in a Recombinant Zoster Vaccine Safety Study. VL - 194 UR - https://stacks.cdc.gov/view/cdc/261899 ER -
Nonuse of Contraception at Conception Due to Partner Objection and Pregnancy-Related Health Care Utilization, Postpartum Health, and Infant Birth Outcomes.

D'Angelo, Denise V. ;

Bombard, Jennifer M.

April 2025 | Journal of Women's Health (2002), 2025, v. 34, no. 4

Reproductive coercion has been associated with adverse reproductive health experiences. This study examined the relationship between nonuse of contraception due to partner objection, one aspect of reproductive coercion, and selected pregnancy-related outcomes.We used 2016-2020 data from the Pregnancy Risk Assessment Monitoring System in 22 jurisdic ...

10/09/2026

Supporting Files

Title : Nonuse of Contraception at Conception Due to Partner Objection and Pregnancy-Related Health Care Utilization, Postpartum Health, and Infant Birth Outcomes. Personal Author(s) : D'Angelo, Denise V.;Bombard, Jennifer M.;Basile, Kathleen C.;Lee, Rosalyn D.;Ruvalcaba, Yanet;Clayton, Heather;Robbins, Cheryl L.; Published Date : April 2025 Pages in Document : 525-538 (23 pdf pages) Source : Journal of Women's Health (2002), 2025, v. 34, no. 4 DOI : https://doi.org/10.1089/jwh.2024.0535 Journal Title : Journal of Women's Health (2002)
D'Angelo, D. V., Bombard, J. M., Basile, K. C., Lee, R. D., Ruvalcaba, Y., Clayton, H., & Robbins, C. L. (2025). Nonuse of Contraception at Conception Due to Partner Objection and Pregnancy-Related Health Care Utilization, Postpartum Health, and Infant Birth Outcomes. Journal of Women's Health (2002), 34(4). https://doi.org/10.1089/jwh.2024.0535

D'Angelo, Denise V., Jennifer M. Bombard, Kathleen C. Basile, Rosalyn D. Lee, Yanet Ruvalcaba, Heather Clayton, and Cheryl L. Robbins. "Nonuse of Contraception at Conception Due to Partner Objection and Pregnancy-Related Health Care Utilization, Postpartum Health, and Infant Birth Outcomes." Journal of Women's Health (2002) 34, no. 4 (2025). https://doi.org/10.1089/jwh.2024.0535.

D'Angelo, Denise V., et al. "Nonuse of Contraception at Conception Due to Partner Objection and Pregnancy-Related Health Care Utilization, Postpartum Health, and Infant Birth Outcomes." Journal of Women's Health (2002), vol. 34, no. 4, 2025. Stacks. https://doi.org/10.1089/jwh.2024.0535.
Export RIS Citation Information. TY - Journal Article AU - D'Angelo, Denise V. AU - Bombard, Jennifer M. AU - Basile, Kathleen C. AU - Lee, Rosalyn D. AU - Ruvalcaba, Yanet AU - Clayton, Heather AU - Robbins, Cheryl L. AB - Reproductive coercion has been associated with adverse reproductive health experiences. This study examined the relationship between nonuse of contraception due to partner objection, one aspect of reproductive coercion, and selected pregnancy-related outcomes. AB - We used 2016-2020 data from the Pregnancy Risk Assessment Monitoring System in 22 jurisdictions to assess the prevalence of nonuse of contraception due to a partner objection by select characteristics among individuals with a recent live birth who reported an unintended pregnancy. We calculated adjusted prevalence ratios (aPRs) to understand associations with health care utilization, postpartum behaviors and experiences, postpartum contraceptive use, and infant birth outcomes. AB - Among people with a recent live birth in the study jurisdictions ( AB - = 29,071), approximately 5% reported nonuse of contraception due to a partner objection and unintended pregnancy. This experience was associated with lower prevalence of attending a health care visit before pregnancy (aPR 0.8, 95% confidence interval [CI] 0.7-0.9), first trimester prenatal care, and attending a postpartum checkup (aPR 0.7, 95% CI 0.6-0.9 for both). Higher prevalence was observed for postpartum depressive symptoms (aPR 1.3, 95% CI 1.1-1.6) and partner objecting to using birth control postpartum (aPR 2.8, 95% CI 2.1-3.9). AB - Nonuse of contraception due to a partner objection at conception was associated with poor mental health and lower health care utilization around the time of pregnancy. Prevention efforts may include strategies that ensure provider screening for intimate partner violence, and evidence-based approaches that teach about healthy relationships, enhance self-efficacy, and address underlying drivers of violence. AB - Author manuscript AN - cdc:261898 C4 - PMC11957929 DO - https://doi.org/10.1089/jwh.2024.0535 IS - 4 J2 - Journal of Women's Health (2002) KW - Pregnancy KW - Female KW - Postpartum Period KW - Coercion KW - Depression, Postpartum KW - Contraception KW - Young Adult KW - Infant, Newborn KW - Mental Health KW - Patient Acceptance of Health Care KW - Contraception Behavior KW - Maternal Health KW - Male KW - Humans KW - Pregnancy Outcome KW - Pregnancy, Unplanned KW - Adult KW - reproductive coercion KW - intimate partner violence KW - pregnancy KW - contraceptive use KW - PRAMS KW - Contraception Behavior KW - Pregnancy, Unplanned KW - Patient Acceptance of Health Care KW - Pregnancy Outcome KW - Maternal Health KW - Postpartum Period KW - Depression, Postpartum KW - Mental Health KW - Coercion KW - Contraception KW - Humans KW - Male KW - Female KW - Pregnancy KW - Infant, Newborn KW - Young Adult KW - Adult LA - eng PY - 2025 T2 - Journal of Women's Health (2002) T2 - Journal of Women's Health (2002), 2025, v. 34, no. 4 TI - Nonuse of Contraception at Conception Due to Partner Objection and Pregnancy-Related Health Care Utilization, Postpartum Health, and Infant Birth Outcomes. VL - 34 UR - https://stacks.cdc.gov/view/cdc/261898 ER -
Rotavirus Vaccine Effectiveness Stratified by National-Level Characteristics: an Introduction to the 24-Country MNSSTER-V Project, 2007-2023.

Burnett, Eleanor ;

Umana, Jazmina

August 2025 | The Journal of Infectious Diseases, 2025, v. 232, no. 2

Rotavirus vaccines are moderately protective against illness in settings with high compared with low mortality rates. Vaccine effectiveness (VE) evaluations may clarify our understanding of these disparities, but estimates among key subpopulations and against rare outcomes are not available in many analyses due to sample size. We combined 25 data s ...

10/09/2026

Supporting Files

Title : Rotavirus Vaccine Effectiveness Stratified by National-Level Characteristics: an Introduction to the 24-Country MNSSTER-V Project, 2007-2023. Personal Author(s) : Burnett, Eleanor;Umana, Jazmina;Anwari, Palwasha;Mujuru, Hilda A.;Groome, Michele J.;Van Trang, Nguyen;Iniguez, Volga;Gheorghita, Stela;Sahakyan, Gayane;Nazurdinov, Anvar;Michael, Fausta;Mandomando, Inacio;Desormeaux, Anne Marie;Eraliev, Umid;Enweronu-Laryea, Christabel;Nalunkuma, Cissy;Bonkoungou, Isidore;Muhsen, Khitam;Lungayo, Christophe Luhata;Omore, Richard;Goldfarb, David M;Robinson, Annick Lalaina;McCracken, John;Uwimana, Jeannine;N'Zue, Kofi;Rey-Benito, Gloria;Weldegebriel, Goitom;Mwenda, Jason M.;Parashar, Umesh D.;Tate, Jacqueline E.; Published Date : August 2025 Pages in Document : 308-315 (15 pdf pages) Source : The Journal of Infectious Diseases, 2025, v. 232, no. 2 DOI : https://doi.org/10.1093/infdis/jiae597 Journal Title : The Journal of Infectious Diseases
Burnett, E., Umana, J., Anwari, P., Mujuru, H. A., Groome, M. J., Van Trang, N., Iniguez, V., Gheorghita, S., Sahakyan, G., Nazurdinov, A., Michael, F., Mandomando, I., Desormeaux, A. M., Eraliev, U., Enweronu-Laryea, C., Nalunkuma, C., Bonkoungou, I., Muhsen, K., Lungayo, C. L., ... Tate, J. E. (2025). Rotavirus Vaccine Effectiveness Stratified by National-Level Characteristics: an Introduction to the 24-Country MNSSTER-V Project, 2007-2023. The Journal of Infectious Diseases, 232(2). https://doi.org/10.1093/infdis/jiae597

Burnett, Eleanor, Jazmina Umana, Palwasha Anwari, Hilda A. Mujuru, Michele J. Groome, Nguyen Van Trang, and Volga Iniguez, et al.. "Rotavirus Vaccine Effectiveness Stratified by National-Level Characteristics: an Introduction to the 24-Country MNSSTER-V Project, 2007-2023." The Journal of Infectious Diseases 232, no. 2 (2025). https://doi.org/10.1093/infdis/jiae597.

Burnett, Eleanor, et al. "Rotavirus Vaccine Effectiveness Stratified by National-Level Characteristics: an Introduction to the 24-Country MNSSTER-V Project, 2007-2023." The Journal of Infectious Diseases, vol. 232, no. 2, 2025. Stacks. https://doi.org/10.1093/infdis/jiae597.
Export RIS Citation Information. TY - Journal Article AU - Burnett, Eleanor AU - Umana, Jazmina AU - Anwari, Palwasha AU - Mujuru, Hilda A. AU - Groome, Michele J. AU - Van Trang, Nguyen AU - Iniguez, Volga AU - Gheorghita, Stela AU - Sahakyan, Gayane AU - Nazurdinov, Anvar AU - Michael, Fausta AU - Mandomando, Inacio AU - Desormeaux, Anne Marie AU - Eraliev, Umid AU - Enweronu-Laryea, Christabel AU - Nalunkuma, Cissy AU - Bonkoungou, Isidore AU - Muhsen, Khitam AU - Lungayo, Christophe Luhata AU - Omore, Richard AU - Goldfarb, David M AU - Robinson, Annick Lalaina AU - McCracken, John AU - Uwimana, Jeannine AU - N'Zue, Kofi AU - Rey-Benito, Gloria AU - Weldegebriel, Goitom AU - Mwenda, Jason M. AU - Parashar, Umesh D. AU - Tate, Jacqueline E. AB - Rotavirus vaccines are moderately protective against illness in settings with high compared with low mortality rates. Vaccine effectiveness (VE) evaluations may clarify our understanding of these disparities, but estimates among key subpopulations and against rare outcomes are not available in many analyses due to sample size. We combined 25 data sets from test-negative design case-control evaluations in 24 countries that enrolled children with medically attended diarrhea, laboratory-confirmed rotavirus stool testing, and documented vaccination status. We calculated rotavirus VE stratified by country-level characteristics. AB - Children 3-59 months old with birthdates and surveillance hospital arrival dates were included; other variables were standardized as available. Children were considered vaccinated if they received ≥1 dose of rotavirus vaccine >14 days before arrival. We summarized child- and country-level characteristics, including national <5-year-old mortality rate (U5M). Following the manufacturer recommended dose schedule, complete- and partial-series adjusted VE were estimated using logistic regression models. AB - We included 6626 rotavirus-positive children (case patients) and 19 459 rotavirus negative children (controls). Adjusted complete-series VE was significantly higher among children from countries in the low and medium U5M stratum (74% [95% confidence interval, 64%-81%]) compared with all groups within the high U5M stratum (range, 52% [42%-60%]) to 46% [31%-57%]). Partial-series estimates were lower than complete-series estimates. AB - These findings are consistent with the published literature, though they suggest heterogeneity in vaccine performance within broad child mortality rate levels. Our findings also highlight the importance of complete-series vaccination. AB - Author manuscript AN - cdc:261897 C4 - PMC12442247 DO - https://doi.org/10.1093/infdis/jiae597 IS - 2 J2 - The Journal of Infectious Diseases KW - Rotavirus Vaccines KW - Diarrhea KW - Female KW - Vaccination KW - Infant KW - Vaccine Efficacy KW - Case-Control Studies KW - Male KW - Humans KW - Child, Preschool KW - Rotavirus KW - Rotavirus Infections KW - Rotavirus KW - diarrhea KW - vaccine KW - immunization KW - rotavirus vaccine KW - Humans KW - Rotavirus Vaccines KW - Rotavirus Infections KW - Infant KW - Vaccine Efficacy KW - Child, Preschool KW - Case-Control Studies KW - Male KW - Female KW - Vaccination KW - Rotavirus KW - Diarrhea LA - eng PY - 2025 T2 - The Journal of Infectious Diseases T2 - The Journal of Infectious Diseases, 2025, v. 232, no. 2 TI - Rotavirus Vaccine Effectiveness Stratified by National-Level Characteristics: an Introduction to the 24-Country MNSSTER-V Project, 2007-2023. VL - 232 UR - https://stacks.cdc.gov/view/cdc/261897 ER -
Importance of Fetal Alcohol Spectrum Disorders Prevention and Intervention.

Donaldson, Tom ;

Dang, Elizabeth P.

April 2025 | Substance Use & Addiction Journal, 2025, v. 46, no. 2

The consumption of alcohol and other substances during pregnancy can impair prenatal development. While scientifically informed public health measures have raised awareness of the risks of harmful prenatal substance exposures, the use of alcohol and other substances during pregnancy continues to rise. The successful dissemination of consistent mess ...

10/09/2026

Supporting Files

Title : Importance of Fetal Alcohol Spectrum Disorders Prevention and Intervention. Personal Author(s) : Donaldson, Tom;Dang, Elizabeth P.;Pierce-Bulger, Marilyn;Mitchell, Kathleen T.;Kachor, Andy R.;Arvizu, Rosa; Published Date : April 2025 Pages in Document : 413-420 (13 pdf pages) Source : Substance Use & Addiction Journal, 2025, v. 46, no. 2 DOI : https://doi.org/10.1177/29767342241300797 Journal Title : Substance Use & Addiction Journal
Donaldson, T., Dang, E. P., Pierce-Bulger, M., Mitchell, K. T., Kachor, A. R., & Arvizu, R. (2025). Importance of Fetal Alcohol Spectrum Disorders Prevention and Intervention. Substance Use & Addiction Journal, 46(2). https://doi.org/10.1177/29767342241300797

Donaldson, Tom, Elizabeth P. Dang, Marilyn Pierce-Bulger, Kathleen T. Mitchell, Andy R. Kachor, and Rosa Arvizu. "Importance of Fetal Alcohol Spectrum Disorders Prevention and Intervention." Substance Use & Addiction Journal 46, no. 2 (2025). https://doi.org/10.1177/29767342241300797.

Donaldson, Tom, et al. "Importance of Fetal Alcohol Spectrum Disorders Prevention and Intervention." Substance Use & Addiction Journal, vol. 46, no. 2, 2025. Stacks. https://doi.org/10.1177/29767342241300797.
Export RIS Citation Information. TY - Journal Article AU - Donaldson, Tom AU - Dang, Elizabeth P. AU - Pierce-Bulger, Marilyn AU - Mitchell, Kathleen T. AU - Kachor, Andy R. AU - Arvizu, Rosa AB - The consumption of alcohol and other substances during pregnancy can impair prenatal development. While scientifically informed public health measures have raised awareness of the risks of harmful prenatal substance exposures, the use of alcohol and other substances during pregnancy continues to rise. The successful dissemination of consistent messaging, health care professional education and training, and universal implementation of clinical interventions may help reduce drinking in pregnancy and prevent fetal alcohol spectrum disorders (FASDs), a constellation of developmental disabilities and birth defects caused by alcohol use during pregnancy. Alcohol screening and brief intervention (alcohol SBI) is an evidence-based preventive practice that enables early identification of excessive drinking and intervention prior to serious consequences. Routine clinical implementation of alcohol SBI has been shown to effectively reduce excessive alcohol consumption among adults, including pregnant people. Many barriers prevent widespread implementation of the practice: a lack of health care professional knowledge of the prevalence and implications of prenatal alcohol exposure, stigma surrounding individuals who use substances potentially harmful to their pregnancy, resistance to public health messages encouraging alcohol avoidance during pregnancy, and discomfort and hesitancy with alcohol SBI procedures among practitioners. The Centers for Disease Control and Prevention (CDC) leads the public health effort to prevent alcohol use during pregnancy and improve identification of and care for children living with FASDs. CDC partners with health systems, health care professional associations, universities, and community-based networks to promote alcohol SBI as an effective but underused preventive health service. This special section consisting of 6 articles including this introductory commentary represents the efforts of 11 CDC projects and their partners to demonstrate the rationale for FASD prevention and intervention, engage health care disciplines to expand prevention messaging and education for providers, develop practical approaches for implementing alcohol SBI in diverse clinical settings, and prevent alcohol use in pregnancy and FASDs. AB - Author manuscript AN - cdc:261896 C4 - PMC11934075 DO - https://doi.org/10.1177/29767342241300797 IS - 2 J2 - Substance Use & Addiction Journal KW - Pregnancy KW - Female KW - Alcohol Drinking KW - Fetal Alcohol Spectrum Disorders KW - Humans KW - Centers for Disease Control and Prevention, U.S. KW - fetal alcohol spectrum disorders (FASDs) KW - prenatal alcohol exposure KW - alcohol use disorder KW - substance use disorder KW - stigma KW - screening and brief intervention (SBI) KW - public health KW - primary care KW - pregnancy KW - Humans KW - Fetal Alcohol Spectrum Disorders KW - Pregnancy KW - Female KW - Alcohol Drinking KW - Centers for Disease Control and Prevention, U.S. LA - eng PY - 2025 T2 - Substance Use & Addiction Journal T2 - Substance Use & Addiction Journal, 2025, v. 46, no. 2 TI - Importance of Fetal Alcohol Spectrum Disorders Prevention and Intervention. VL - 46 UR - https://stacks.cdc.gov/view/cdc/261896 ER -
Exposure Duration and Cerebral Amyloidosis in the Olfactory Cortex of World Trade Center Responders: a Positron Emission Tomography and Magnetic Resonance Imaging Study.

Kritikos, Minos ;

Zhou, Juin-Wan

January 2025 | Journal of Alzheimer'S Disease : JAD, 2025, v. 103, no. 2

Amyloid-β proteins, a hallmark of Alzheimer's disease, are believed to play an adaptive role in the cerebral immune response.Amyloid is believed to play a role in cerebral immune response and could play a similar role in response to air pollution exposures. In the present study, we examined whether WTC exposure duration was associated with cerebral ...

10/09/2026

Supporting Files

Title : Exposure Duration and Cerebral Amyloidosis in the Olfactory Cortex of World Trade Center Responders: a Positron Emission Tomography and Magnetic Resonance Imaging Study. Personal Author(s) : Kritikos, Minos;Zhou, Juin-Wan;Huang, Chuan;Gandy, Sam;Pellecchia, Alison C.;Santiago-Michels, Stephanie;Carr, Melissa A.;Islam, Shabab;Yang, Yuan;Horton, Megan K.;Lucchini, Roberto G.;Franceschi, Ana M.;Bangiyev, Lev;Vaska, Paul;Clouston, Sean A. P.;Luft, Benjamin J.; Published Date : January 2025 Pages in Document : 383-395 (21 pdf pages) Source : Journal of Alzheimer'S Disease : JAD, 2025, v. 103, no. 2 DOI : https://doi.org/10.1177/13872877241302350 Journal Title : Journal of Alzheimer'S Disease : JAD
Kritikos, M., Zhou, J. W., Huang, C., Gandy, S., Pellecchia, A. C., Santiago-Michels, S., Carr, M. A., Islam, S., Yang, Y., Horton, M. K., Lucchini, R. G., Franceschi, A. M., Bangiyev, L., Vaska, P., Clouston, S. A. P., & Luft, B. J. (2025). Exposure Duration and Cerebral Amyloidosis in the Olfactory Cortex of World Trade Center Responders: a Positron Emission Tomography and Magnetic Resonance Imaging Study. Journal of Alzheimer'S Disease : JAD, 103(2). https://doi.org/10.1177/13872877241302350

Kritikos, Minos, Juin-Wan Zhou, Chuan Huang, Sam Gandy, Alison C. Pellecchia, Stephanie Santiago-Michels, and Melissa A. Carr, et al.. "Exposure Duration and Cerebral Amyloidosis in the Olfactory Cortex of World Trade Center Responders: a Positron Emission Tomography and Magnetic Resonance Imaging Study." Journal of Alzheimer'S Disease : JAD 103, no. 2 (2025). https://doi.org/10.1177/13872877241302350.

Kritikos, Minos, et al. "Exposure Duration and Cerebral Amyloidosis in the Olfactory Cortex of World Trade Center Responders: a Positron Emission Tomography and Magnetic Resonance Imaging Study." Journal of Alzheimer'S Disease : JAD, vol. 103, no. 2, 2025. Stacks. https://doi.org/10.1177/13872877241302350.
Export RIS Citation Information. TY - Journal Article AU - Kritikos, Minos AU - Zhou, Juin-Wan AU - Huang, Chuan AU - Gandy, Sam AU - Pellecchia, Alison C. AU - Santiago-Michels, Stephanie AU - Carr, Melissa A. AU - Islam, Shabab AU - Yang, Yuan AU - Horton, Megan K. AU - Lucchini, Roberto G. AU - Franceschi, Ana M. AU - Bangiyev, Lev AU - Vaska, Paul AU - Clouston, Sean A. P. AU - Luft, Benjamin J. AB - Amyloid-β proteins, a hallmark of Alzheimer's disease, are believed to play an adaptive role in the cerebral immune response. AB - Amyloid is believed to play a role in cerebral immune response and could play a similar role in response to air pollution exposures. In the present study, we examined whether WTC exposure duration was associated with cerebral amyloidosis in WTC responders. AB - WTC responders (aged 44-65 years) who varied in exposure duration but did not use personalized protective equipment were assessed using positron-emission tomography with [ AB - F]-Florbetaben. The outcome was the cortical [ AB - F]-Florbetaben burden, measured using regional standardized uptake value ratios (SUVRs) in 34 Desikan-Killiany regions of interest. Spearman's AB - and generalized linear models were used to estimate correlations between WTC exposure duration and cortical [ AB - F]-Florbetaben SUVR. Cognitive and behavioral symptoms were measured. Magnetic resonance imaging was used to measure cortical thickness and diffusivity. AB - The mean age of imaged responders was 56 years old. WTC exposure duration was associated with olfactory [ AB - F]-Florbetaben SUVR (Spearman's AB - = 0.43, p = 0.011), which was in turn associated with elevated [ AB - F]-Florbetaben SUVR in ventral regions ( AB - = 0.41, p = 0.016). Cortical [ AB - F]-Florbetaben in ventral regions was associated with reduced response speed ( AB - = -0.72, p < 0.001), was co-located with cortical diffusivity across regions in the parietal and frontal lobes and reduced cortical thickness in the isthmus cingulate ( AB - = -0.53, p = 0.001). AB - Low-grade amyloidosis in the olfactory and frontal lobes was associated with WTC exposure duration. Future work should examine whether low-grade amyloidosis is correlated with the location or distribution of neurofibrillary tangles in WTC responders. AB - Author manuscript AN - cdc:261895 C4 - PMC12261283 DO - https://doi.org/10.1177/13872877241302350 IS - 2 J2 - Journal of Alzheimer'S Disease : JAD KW - Occupational Exposure KW - Amyloidosis KW - Female KW - Olfactory Pathways KW - Aged KW - Stilbenes KW - Magnetic Resonance Imaging KW - Positron-Emission Tomography KW - Aniline Compounds KW - Male KW - Middle Aged KW - Humans KW - September 11 Terrorist Attacks KW - Time Factors KW - Adult KW - Amyloidosis KW - Alzheimer's disease KW - World Trade Center KW - First Responders KW - cognitive impairment KW - Humans KW - Middle Aged KW - Male KW - Positron-Emission Tomography KW - Female KW - Magnetic Resonance Imaging KW - Adult KW - Aged KW - September 11 Terrorist Attacks KW - Amyloidosis KW - Aniline Compounds KW - Olfactory Pathways KW - Time Factors KW - Occupational Exposure KW - Stilbenes LA - eng PY - 2025 T2 - Journal of Alzheimer'S Disease : JAD T2 - Journal of Alzheimer'S Disease : JAD, 2025, v. 103, no. 2 TI - Exposure Duration and Cerebral Amyloidosis in the Olfactory Cortex of World Trade Center Responders: a Positron Emission Tomography and Magnetic Resonance Imaging Study. VL - 103 UR - https://stacks.cdc.gov/view/cdc/261895 ER -
Pharmacists' Answer to the COVID-19 Pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 Vaccination Across Sociodemographic Characteristics-United States.

El Kalach, Roua ;

Jones-Jack, Nkenge H.

January 1, 2026 | Journal of the American Pharmacists Association: JAPhA, 2026, v. 65, no. 1

The Federal Retail Pharmacy Program (FRPP) integrated pharmacies as partners in the national effort to maximize vaccination during the COVID-19 public health emergency.The objective of this study was to quantify the contribution of pharmacies participating in FRPP to COVID-19 vaccination efforts during December 2020-September 2023 across sociodemog ...

10/09/2026

Supporting Files

Title : Pharmacists' Answer to the COVID-19 Pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 Vaccination Across Sociodemographic Characteristics-United States. Personal Author(s) : El Kalach, Roua;Jones-Jack, Nkenge H.;Grabenstein, John D.;Elam, Mattie;Olorukooba, Abdulhakeem A.;deMartino, Amee K.;Vazquez, Marley;Stokley, Shannon;Meyer, Sarah A.;Wang, Teresa W.;Himsel, Andrew;Medernach, Connor;Jenkins, Kendra;Marovich, Stacey;Bradley, Meranda D.;Manns, Brian J.;Romerhausen, Doug;Moore, Lori B.; Published Date : January 1, 2026 Pages in Document : 102305 (15 pdf pages) Source : Journal of the American Pharmacists Association: JAPhA, 2026, v. 65, no. 1 DOI : https://doi.org/10.1016/j.japh.2024.102305 Journal Title : Journal of the American Pharmacists Association: JAPhA
El Kalach, R., Jones-Jack, N. H., Grabenstein, J. D., Elam, M., Olorukooba, A. A., deMartino, A. K., Vazquez, M., Stokley, S., Meyer, S. A., Wang, T. W., Himsel, A., Medernach, C., Jenkins, K., Marovich, S., Bradley, M. D., Manns, B. J., Romerhausen, D., & Moore, L. B. (2026). Pharmacists' Answer to the COVID-19 Pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 Vaccination Across Sociodemographic Characteristics-United States. Journal of the American Pharmacists Association: JAPhA, 65(1). https://doi.org/10.1016/j.japh.2024.102305

El Kalach, Roua, Nkenge H. Jones-Jack, John D. Grabenstein, Mattie Elam, Abdulhakeem A. Olorukooba, Amee K. deMartino, and Marley Vazquez, et al.. "Pharmacists' Answer to the COVID-19 Pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 Vaccination Across Sociodemographic Characteristics-United States." Journal of the American Pharmacists Association: JAPhA 65, no. 1 (2026). https://doi.org/10.1016/j.japh.2024.102305.

El Kalach, Roua, et al. "Pharmacists' Answer to the COVID-19 Pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 Vaccination Across Sociodemographic Characteristics-United States." Journal of the American Pharmacists Association: JAPhA, vol. 65, no. 1, 2026. Stacks. https://doi.org/10.1016/j.japh.2024.102305.
Export RIS Citation Information. TY - Journal Article AU - El Kalach, Roua AU - Jones-Jack, Nkenge H. AU - Grabenstein, John D. AU - Elam, Mattie AU - Olorukooba, Abdulhakeem A. AU - deMartino, Amee K. AU - Vazquez, Marley AU - Stokley, Shannon AU - Meyer, Sarah A. AU - Wang, Teresa W. AU - Himsel, Andrew AU - Medernach, Connor AU - Jenkins, Kendra AU - Marovich, Stacey AU - Bradley, Meranda D. AU - Manns, Brian J. AU - Romerhausen, Doug AU - Moore, Lori B. AB - The Federal Retail Pharmacy Program (FRPP) integrated pharmacies as partners in the national effort to maximize vaccination during the COVID-19 public health emergency. AB - The objective of this study was to quantify the contribution of pharmacies participating in FRPP to COVID-19 vaccination efforts during December 2020-September 2023 across sociodemographic groups in the United States. AB - Data on COVID-19 vaccine doses administered reported to Centers for Disease Control and Prevention by FRPP and jurisdictional immunization information systems of all 50 states, the District of Columbia, and U.S. territories were analyzed to estimate FRPP contributions. AB - Approximately 314.9 million COVID-19 vaccine doses were administered by FRPP throughout this period, constituting 48.9% of all COVID-19 vaccine doses administered. FRPP contributions to COVID-19 vaccination ranged from 12.9% to 56.8% for persons aged 6 months-4 years and 12-17 years, respectively. FRPP made the highest contribution to administering COVID-19 doses to Non-Hispanic Asian (48.7%) and Hispanic/Latino (49.8%) persons. The proportion of COVID-19 doses given by FRPP pharmacies was found to be higher in urban areas (57%) compared with rural areas (45%). AB - FRPP administered a substantial proportion of COVID-19 vaccine doses in the United States and provided vaccine access for persons across a wide range of groups. Pharmacies can complement vaccination efforts during public health emergency situations and in routine vaccination programs. AB - Author manuscript AN - cdc:261894 C4 - PMC11839327 DO - https://doi.org/10.1016/j.japh.2024.102305 IS - 1 J2 - Journal of the American Pharmacists Association: JAPhA KW - Adolescent KW - Female KW - Vaccination KW - Pharmacies KW - Immunization Programs KW - Community Pharmacy Services KW - Aged KW - Young Adult KW - COVID-19 KW - Child KW - Infant KW - COVID-19 Vaccines KW - Pharmacists KW - Male KW - Humans KW - Middle Aged KW - Child, Preschool KW - Sociodemographic Factors KW - Adult KW - Humans KW - COVID-19 KW - COVID-19 Vaccines KW - Adolescent KW - Pharmacists KW - Child KW - Infant KW - Child, Preschool KW - Community Pharmacy Services KW - Vaccination KW - Adult KW - Middle Aged KW - Young Adult KW - Sociodemographic Factors KW - Male KW - Female KW - Immunization Programs KW - Pharmacies KW - Aged LA - eng PY - 2026 T2 - Journal of the American Pharmacists Association: JAPhA T2 - Journal of the American Pharmacists Association: JAPhA, 2026, v. 65, no. 1 TI - Pharmacists' Answer to the COVID-19 Pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 Vaccination Across Sociodemographic Characteristics-United States. VL - 65 UR - https://stacks.cdc.gov/view/cdc/261894 ER -
Suicides and Overdoses at Work: Census of Fatal Occupational Injuries, 2011-2022.

Tiesman, Hope M. ;

Hendricks, Scott

March 2025 | American Journal of Preventive Medicine, 2025, v. 68, no. 3

The worsening life expectancy of middle-aged White Americans due to suicides and substance overdoses has been hypothesized to be caused by various societal conditions. Work is a social determinant of health, but its role in this demographic shift has not been examined. This article describes the characteristics and trends of suicides and overdose f ...

10/09/2026

Supporting Files

Title : Suicides and Overdoses at Work: Census of Fatal Occupational Injuries, 2011-2022. Personal Author(s) : Tiesman, Hope M.;Hendricks, Scott; Published Date : March 2025 Pages in Document : 527-534 (15 pdf pages) Source : American Journal of Preventive Medicine, 2025, v. 68, no. 3 DOI : https://doi.org/10.1016/j.amepre.2024.11.015 Journal Title : American Journal of Preventive Medicine
Tiesman, H. M., & Hendricks, S. (2025). Suicides and Overdoses at Work: Census of Fatal Occupational Injuries, 2011-2022. American Journal of Preventive Medicine, 68(3). https://doi.org/10.1016/j.amepre.2024.11.015

Tiesman, Hope M. and Scott Hendricks. "Suicides and Overdoses at Work: Census of Fatal Occupational Injuries, 2011-2022." American Journal of Preventive Medicine 68, no. 3 (2025). https://doi.org/10.1016/j.amepre.2024.11.015.

Tiesman, Hope M., and Scott Hendricks "Suicides and Overdoses at Work: Census of Fatal Occupational Injuries, 2011-2022." American Journal of Preventive Medicine, vol. 68, no. 3, 2025. Stacks. https://doi.org/10.1016/j.amepre.2024.11.015.
Export RIS Citation Information. TY - Journal Article AU - Tiesman, Hope M. AU - Hendricks, Scott AB - The worsening life expectancy of middle-aged White Americans due to suicides and substance overdoses has been hypothesized to be caused by various societal conditions. Work is a social determinant of health, but its role in this demographic shift has not been examined. This article describes the characteristics and trends of suicides and overdose fatalities occurring in U.S. workplaces among all workers between 2011 and 2022. AB - Data originated from the Census of Fatal Occupational Injury database. Fatality rates were calculated using the Current Population Survey. Fatality rates were calculated and compared among demographic and occupational groups. Annual rates were modeled with a first-order auto-regressive linear regression to account for serial correlation. Analyses were conducted in 2023-2024. AB - Between 2011 and 2022, the rate of workplace overdose fatality rates increased from 0.05 per 100,000 workers to 0.33-an increase of 560%. Workplace suicide rates were relatively stable (0.19 per 100,000 to 0.17). Most industries and occupations experienced significant increases in workplace overdose rates and nonsignificant decreases in workplace suicide rates. The largest workplace overdose rates occurred in the transportation and warehousing industry (0.47, 95% CI=0.27, 0.67) and farming, fishing, and forestry occupations (0.68, 95% CI=0.27, 1.08). AB - Fatal workplace suicides and substance overdoses have different trends and impact industries, occupations, and demographic groups differently. The rise in workplace overdoses deserve immediate attention. AB - Author manuscript AN - cdc:261893 C4 - PMC12376050 DO - https://doi.org/10.1016/j.amepre.2024.11.015 IS - 3 J2 - American Journal of Preventive Medicine KW - Female KW - Suicide KW - Male KW - Occupations KW - Humans KW - Censuses KW - Occupational Injuries KW - Middle Aged KW - Young Adult KW - Workplace KW - Adult KW - Drug Overdose KW - Humans KW - Drug Overdose KW - Male KW - Adult KW - Middle Aged KW - Female KW - Suicide KW - Workplace KW - Occupational Injuries KW - Occupations KW - Young Adult KW - Censuses LA - eng PY - 2025 T2 - American Journal of Preventive Medicine T2 - American Journal of Preventive Medicine, 2025, v. 68, no. 3 TI - Suicides and Overdoses at Work: Census of Fatal Occupational Injuries, 2011-2022. VL - 68 UR - https://stacks.cdc.gov/view/cdc/261893 ER -
Childcare Subsidy Receipt and Reduced Emotional Neglect: Examining Parents' Enhanced Self-efficacy as a Mediator.

Chang, Olivia D. ;

Maguire-Jack, Kathryn

January 2025 | Child Abuse & Neglect, 2025, v. 159

Each year 1.5 million children receive childcare subsidized under the Child Care and Development Fund, which supports working parents with low income in affording childcare; such policies hold promise for reducing child neglect.The current study sought to examine how receiving childcare subsidies might reduce emotional neglect by supporting working ...

10/09/2026

Supporting Files

Title : Childcare Subsidy Receipt and Reduced Emotional Neglect: Examining Parents' Enhanced Self-efficacy as a Mediator. Personal Author(s) : Chang, Olivia D.;Maguire-Jack, Kathryn;Marçal, Katherine E.;Showalter, Kathryn;Park, Yanghyun;Machinga, Rujeko O.;Thibodeau, Eric;Murphy, Catherine A.;Klika, J. Bart; Published Date : January 2025 Pages in Document : 107184 (19 pdf pages) Source : Child Abuse & Neglect, 2025, v. 159 DOI : https://doi.org/10.1016/j.chiabu.2024.107184 Journal Title : Child Abuse & Neglect
Chang, O. D., Maguire-Jack, K., Marçal, K. E., Showalter, K., Park, Y., Machinga, R. O., Thibodeau, E., Murphy, C. A., & Klika, J. B. (2025). Childcare Subsidy Receipt and Reduced Emotional Neglect: Examining Parents' Enhanced Self-efficacy as a Mediator. Child Abuse & Neglect, 159. https://doi.org/10.1016/j.chiabu.2024.107184

Chang, Olivia D., Kathryn Maguire-Jack, Katherine E. Marçal, Kathryn Showalter, Yanghyun Park, Rujeko O. Machinga, Eric Thibodeau, Catherine A. Murphy, and J. Bart Klika. "Childcare Subsidy Receipt and Reduced Emotional Neglect: Examining Parents' Enhanced Self-efficacy as a Mediator." Child Abuse & Neglect 159 (2025). https://doi.org/10.1016/j.chiabu.2024.107184.

Chang, Olivia D., et al. "Childcare Subsidy Receipt and Reduced Emotional Neglect: Examining Parents' Enhanced Self-efficacy as a Mediator." Child Abuse & Neglect, vol. 159, 2025. Stacks. https://doi.org/10.1016/j.chiabu.2024.107184.
Export RIS Citation Information. TY - Journal Article AU - Chang, Olivia D. AU - Maguire-Jack, Kathryn AU - Marçal, Katherine E. AU - Showalter, Kathryn AU - Park, Yanghyun AU - Machinga, Rujeko O. AU - Thibodeau, Eric AU - Murphy, Catherine A. AU - Klika, J. Bart AB - Each year 1.5 million children receive childcare subsidized under the Child Care and Development Fund, which supports working parents with low income in affording childcare; such policies hold promise for reducing child neglect. AB - The current study sought to examine how receiving childcare subsidies might reduce emotional neglect by supporting working parents' self-efficacy. AB - Data came from the Future of Families and Child Well-being Study (FFCWS) which oversampled births to unmarried mothers in large U.S. cities. The current study focused on the third wave of the study, when focal children were age three, and when many parents were using childcare. AB - The associations between childcare subsidy receipt, parent self-efficacy, and emotional neglect were analyzed with path modeling using a structural equation modeling framework. Furthermore, we estimated the indirect effect of subsidy receipt on emotional neglect via parent self-efficacy. AB - Receipt of the childcare subsidy was significantly associated with decreased emotional neglect (b = -1.24, p = .045) and increased parent self-efficacy (b = .16, p = .004). Self-efficacy was significantly associated with decreased emotional neglect (b = -1.27, p < .001). The path model results showed a significant mediating effect of self-efficacy on the link between receipt of the childcare subsidy and emotional neglect (b = -.20, p = .01). AB - The present study highlights the potential for increasing access to affordable, high-quality childcare to improve parent and child well-being. Subsidies that increase access to high-quality childcare can benefit both mothers and children. AB - Author manuscript AN - cdc:261892 C4 - PMC12225609 DO - https://doi.org/10.1016/j.chiabu.2024.107184 J2 - Child Abuse & Neglect KW - Self Efficacy KW - Female KW - Public Assistance KW - Parents KW - Male KW - Humans KW - Poverty KW - Child, Preschool KW - Child Abuse KW - Adult KW - Child Care KW - emotional neglect KW - childcare subsidies KW - self-efficacy KW - maltreatment KW - Humans KW - Self Efficacy KW - Female KW - Male KW - Child Care KW - Child, Preschool KW - Child Abuse KW - Adult KW - Parents KW - Poverty KW - Public Assistance LA - eng PY - 2025 T2 - Child Abuse & Neglect T2 - Child Abuse & Neglect, 2025, v. 159 TI - Childcare Subsidy Receipt and Reduced Emotional Neglect: Examining Parents' Enhanced Self-efficacy as a Mediator. VL - 159 UR - https://stacks.cdc.gov/view/cdc/261892 ER -
Crimean-Congo Hemorrhagic Fever Virus Replicon Particle Vaccine is Safe and Elicits Functional, Non-neutralizing Anti-nucleoprotein Antibodies and T Cell Activation in Rhesus Macaques.

Kleymann, Alyssa ;

Karaaslan, Elif

January 2025 | Antiviral Research, 2025, v. 233

Advancement of vaccine candidates that demonstrate protective efficacy in screening studies necessitates detailed safety and immunogenicity investigations in pre-clinical models. A non-spreading Crimean-Congo hemorrhagic fever virus (CCHFV) viral replicon particle (VRP) vaccine was developed for single-dose administration to protect against disease ...

10/09/2026

Supporting Files

Title : Crimean-Congo Hemorrhagic Fever Virus Replicon Particle Vaccine is Safe and Elicits Functional, Non-neutralizing Anti-nucleoprotein Antibodies and T Cell Activation in Rhesus Macaques. Personal Author(s) : Kleymann, Alyssa;Karaaslan, Elif;Scholte, Florine E.M.;Sorvillo, Teresa E.;Welch, Stephen R.;Bergeron, Éric;Elser, Stephanie;Almanzar-Jordan, Melvyn R.;Velazquez, Eric;Genzer, Sarah C.;Jean, Sherrie M.;Spiropoulou, Christina F.;Spengler, Jessica R.; Published Date : January 2025 Pages in Document : 106045 (18 pdf pages) Source : Antiviral Research, 2025, v. 233 DOI : https://doi.org/10.1016/j.antiviral.2024.106045 Journal Title : Antiviral Research
Kleymann, A., Karaaslan, E., Scholte, F. E., Sorvillo, T. E., Welch, S. R., Bergeron, �., Elser, S., Almanzar-Jordan, M. R., Velazquez, E., Genzer, S. C., Jean, S. M., Spiropoulou, C. F., & Spengler, J. R. (2025). Crimean-Congo Hemorrhagic Fever Virus Replicon Particle Vaccine is Safe and Elicits Functional, Non-neutralizing Anti-nucleoprotein Antibodies and T Cell Activation in Rhesus Macaques. Antiviral Research, 233. https://doi.org/10.1016/j.antiviral.2024.106045

Kleymann, Alyssa, Elif Karaaslan, Florine E.M. Scholte, Teresa E. Sorvillo, Stephen R. Welch, Éric Bergeron, and Stephanie Elser, et al.. "Crimean-Congo Hemorrhagic Fever Virus Replicon Particle Vaccine is Safe and Elicits Functional, Non-neutralizing Anti-nucleoprotein Antibodies and T Cell Activation in Rhesus Macaques." Antiviral Research 233 (2025). https://doi.org/10.1016/j.antiviral.2024.106045.

Kleymann, Alyssa, et al. "Crimean-Congo Hemorrhagic Fever Virus Replicon Particle Vaccine is Safe and Elicits Functional, Non-neutralizing Anti-nucleoprotein Antibodies and T Cell Activation in Rhesus Macaques." Antiviral Research, vol. 233, 2025. Stacks. https://doi.org/10.1016/j.antiviral.2024.106045.
Export RIS Citation Information. TY - Journal Article AU - Kleymann, Alyssa AU - Karaaslan, Elif AU - Scholte, Florine E.M. AU - Sorvillo, Teresa E. AU - Welch, Stephen R. AU - Bergeron, Éric AU - Elser, Stephanie AU - Almanzar-Jordan, Melvyn R. AU - Velazquez, Eric AU - Genzer, Sarah C. AU - Jean, Sherrie M. AU - Spiropoulou, Christina F. AU - Spengler, Jessica R. AB - Advancement of vaccine candidates that demonstrate protective efficacy in screening studies necessitates detailed safety and immunogenicity investigations in pre-clinical models. A non-spreading Crimean-Congo hemorrhagic fever virus (CCHFV) viral replicon particle (VRP) vaccine was developed for single-dose administration to protect against disease. To date, several studies have supported safety, immunogenicity, and efficacy of the CCHF VRP in multiple highly sensitive murine models of lethal disease, but the VRP had yet to be evaluated in large animals. Here, we performed studies in non-human primates to further evaluate clinical utility of the VRP vaccine. Twelve adult male and female rhesus macaques were vaccinated intramuscularly and clinical monitoring was performed daily for 28 days. At 3, 7, 14, 21, and 28 days post vaccination, animals were sedated for more detailed clinical assessment; for quantification of vaccine presence in blood and mucosal samples; and for evaluation of hematology, plasma inflammatory markers, and immunogenicity. Consistent with findings in mice, vaccination was well tolerated, with no clinical alterations nor indication of vaccine spread or shedding. In addition, vaccination induced both humoral and cell-mediated responses, with immune profile and kinetics also corroborating data from small animal models. These studies provide key data in non-human primates further supporting development of the VRP for human clinical use. AB - Author manuscript AN - cdc:261891 C4 - PMC11871586 DO - https://doi.org/10.1016/j.antiviral.2024.106045 J2 - Antiviral Research KW - Lymphocyte Activation KW - Antibodies, Neutralizing KW - Female KW - Vaccination KW - Animals KW - Viral Vaccines KW - Hemorrhagic Fever, Crimean KW - Immunogenicity, Vaccine KW - Replicon KW - Hemorrhagic Fever Virus, Crimean-Congo KW - Antibodies, Viral KW - Male KW - Macaca mulatta KW - Disease Models, Animal KW - T-Lymphocytes KW - Crimean-Congo hemorrhagic fever virus KW - Vaccine KW - Safety KW - Immune response KW - Non-human primate KW - Animals KW - Macaca mulatta KW - Female KW - Hemorrhagic Fever Virus, Crimean-Congo KW - Antibodies, Viral KW - Male KW - T-Lymphocytes KW - Viral Vaccines KW - Hemorrhagic Fever, Crimean KW - Lymphocyte Activation KW - Replicon KW - Vaccination KW - Antibodies, Neutralizing KW - Disease Models, Animal KW - Immunogenicity, Vaccine LA - eng PY - 2025 T2 - Antiviral Research T2 - Antiviral Research, 2025, v. 233 TI - Crimean-Congo Hemorrhagic Fever Virus Replicon Particle Vaccine is Safe and Elicits Functional, Non-neutralizing Anti-nucleoprotein Antibodies and T Cell Activation in Rhesus Macaques. VL - 233 UR - https://stacks.cdc.gov/view/cdc/261891 ER -
The Effect of Chelation on Bone pb Stores in Pb Poisoned Children.

Specht, Aaron J. ;

Lin, Yanfen

September 2025 | Journal of Exposure Science & Environmental Epidemiology, 2025, v. 35, no. 5

Lead exposure remains a key problem for children during development. One treatment for lead poisoning is chelation - a topic that remains controversial with varied results. Bone lead serves as a marker of total body burden of lead and encompasses between 60-90% of lead storage in children.In this study, we aimed to identify the change in bone lead ...

10/09/2026

Supporting Files

Title : The Effect of Chelation on Bone pb Stores in Pb Poisoned Children. Personal Author(s) : Specht, Aaron J.;Lin, Yanfen;Xu, Jian;Dickerson, Aisha S.;Yan, Chonghuai;Hu, Howard;Weisskopf, Marc G.;Nie, Linda H.; Published Date : September 2025 Pages in Document : 709-714 (19 pdf pages) Source : Journal of Exposure Science & Environmental Epidemiology, 2025, v. 35, no. 5 DOI : https://doi.org/10.1038/s41370-024-00735-1 Journal Title : Journal of Exposure Science & Environmental Epidemiology
Specht, A. J., Lin, Y., Xu, J., Dickerson, A. S., Yan, C., Hu, H., Weisskopf, M. G., & Nie, L. H. (2025). The Effect of Chelation on Bone pb Stores in Pb Poisoned Children. Journal of Exposure Science & Environmental Epidemiology, 35(5). https://doi.org/10.1038/s41370-024-00735-1

Specht, Aaron J., Yanfen Lin, Jian Xu, Aisha S. Dickerson, Chonghuai Yan, Howard Hu, Marc G. Weisskopf, and Linda H. Nie. "The Effect of Chelation on Bone pb Stores in Pb Poisoned Children." Journal of Exposure Science & Environmental Epidemiology 35, no. 5 (2025). https://doi.org/10.1038/s41370-024-00735-1.

Specht, Aaron J., et al. "The Effect of Chelation on Bone pb Stores in Pb Poisoned Children." Journal of Exposure Science & Environmental Epidemiology, vol. 35, no. 5, 2025. Stacks. https://doi.org/10.1038/s41370-024-00735-1.
Export RIS Citation Information. TY - Journal Article AU - Specht, Aaron J. AU - Lin, Yanfen AU - Xu, Jian AU - Dickerson, Aisha S. AU - Yan, Chonghuai AU - Hu, Howard AU - Weisskopf, Marc G. AU - Nie, Linda H. AB - Lead exposure remains a key problem for children during development. One treatment for lead poisoning is chelation - a topic that remains controversial with varied results. Bone lead serves as a marker of total body burden of lead and encompasses between 60-90% of lead storage in children. AB - In this study, we aimed to identify the change in bone lead as a result of chelation therapy in a group of lead poisoned children (blood lead >25 µg/dL). AB - Upon diagnosis with lead poisoning at Xinhua Hospital in Shanghai, China, children were recruited to our study, had their bone lead levels measured, and underwent one-week of intravenous, in-patient ethylenediaminetetraacetic acid chelation treatment. Up to three clinical visits with the same treatment protocol and bone lead measurements were completed over the two-year study. We measured biomarkers of lead exposure for children exposed via various potential sources, including home contaminants, local industrial emissions, traditional medicines, or lead cookware. AB - We observed significant differences with bone lead after chelation therapy (p < 0.0001), even after calculating a conservative model for theoretical decay from known bone turnover (p = 0.01). The difference identified between our observed change in bone lead and literature established bone lead change significantly increased with more chelation treatments. A significant reduction in bone lead was observed following chelation treatment of children with lead poisoning - a difference that increased more with more chelation. AB - Study results indicate that chelation treatment is effective in reducing bone lead stores in children with initial blood lead levels greater than 25 µg/dL. AB - Lead exposure in children is a consistent problem - drastically impacting health across the life span. After exposure, lead stores in the bone of children serving as a potential endogenous source of exposure for years to decades. Our study demonstrated that chelation therapy, while reducing blood lead levels, additionally reduced bone lead levels. A reduction in bone lead would effectively reduce the potential for endogenous release of lead and restrict the damage done by lead exposure. AB - Author manuscript AN - cdc:261890 C4 - PMC12368868 DO - https://doi.org/10.1038/s41370-024-00735-1 IS - 5 J2 - Journal of Exposure Science & Environmental Epidemiology KW - Adolescent KW - Chelation Therapy KW - Female KW - Lead Poisoning KW - Edetic Acid KW - Chelating Agents KW - Lead KW - Biomarkers KW - Child KW - Infant KW - Male KW - Humans KW - Child, Preschool KW - Bone and Bones KW - Environmental Exposure KW - Humans KW - Lead Poisoning KW - Lead KW - Child, Preschool KW - Female KW - Bone and Bones KW - Male KW - Chelating Agents KW - Child KW - Chelation Therapy KW - Edetic Acid KW - Infant KW - Biomarkers KW - Adolescent KW - Environmental Exposure LA - eng PY - 2025 T2 - Journal of Exposure Science & Environmental Epidemiology T2 - Journal of Exposure Science & Environmental Epidemiology, 2025, v. 35, no. 5 TI - The Effect of Chelation on Bone pb Stores in Pb Poisoned Children. VL - 35 UR - https://stacks.cdc.gov/view/cdc/261890 ER -
Low Sexually Transmitted Infection (STI) Screening and Presumptive Treatment and High STI Positivity Among United States Females Visiting the Emergency Department After Sexual Assault.

Tao, Guoyu ;

Patel, Chirag G

March 2025 | Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine, 2025, v. 32, no. 3

The Centers for Disease Control and Prevention sexually transmitted infection (STI) treatment guidelines state that the decision to provide STI/human immunodeficiency virus (HIV) testing and presumptive treatment after sexual assault (SA) should be made on an individual basis to minimize retraumatization of the patient. However, little is known abo ...

10/09/2026

Supporting Files

Title : Low Sexually Transmitted Infection (STI) Screening and Presumptive Treatment and High STI Positivity Among United States Females Visiting the Emergency Department After Sexual Assault. Personal Author(s) : Tao, Guoyu;Patel, Chirag G;Stanford, Kimberly A.; Published Date : March 2025 Pages in Document : 292-299 (12 pdf pages) Source : Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine, 2025, v. 32, no. 3 DOI : https://doi.org/10.1111/acem.15058 Journal Title : Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
Tao, G., Patel, C. G., & Stanford, K. A. (2025). Low Sexually Transmitted Infection (STI) Screening and Presumptive Treatment and High STI Positivity Among United States Females Visiting the Emergency Department After Sexual Assault. Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine, 32(3). https://doi.org/10.1111/acem.15058

Tao, Guoyu, Chirag G Patel, and Kimberly A. Stanford. "Low Sexually Transmitted Infection (STI) Screening and Presumptive Treatment and High STI Positivity Among United States Females Visiting the Emergency Department After Sexual Assault." Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine 32, no. 3 (2025). https://doi.org/10.1111/acem.15058.

Tao, Guoyu, et al. "Low Sexually Transmitted Infection (STI) Screening and Presumptive Treatment and High STI Positivity Among United States Females Visiting the Emergency Department After Sexual Assault." Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine, vol. 32, no. 3, 2025. Stacks. https://doi.org/10.1111/acem.15058.
Export RIS Citation Information. TY - Journal Article AU - Tao, Guoyu AU - Patel, Chirag G AU - Stanford, Kimberly A. AB - The Centers for Disease Control and Prevention sexually transmitted infection (STI) treatment guidelines state that the decision to provide STI/human immunodeficiency virus (HIV) testing and presumptive treatment after sexual assault (SA) should be made on an individual basis to minimize retraumatization of the patient. However, little is known about STI screening, presumptive treatment, and positivity in the emergency department (ED) setting. The objective of this study was to evaluate STI testing rates and positivity, presumptive gonorrhea and chlamydia treatment, pregnancy testing, and emergency contraception offered to SA survivors in the ED in the United States. AB - The Premier Healthcare Database, a national administrative data set containing health care information from inpatient and hospital-based outpatient encounters, was used. Approximately 30% of encounters have available laboratory test results. ED visits for SA (identified by ICD-10-CM codes) among female patients aged 15-44 years between 2019 and 2023 were included. For patients presenting multiple times to the ED, only the first ED visit after SA was included. AB - Of 49,047 total visits where females ages 15-44 years presented to the ED for SA, chlamydia, gonorrhea, syphilis, and HIV tests were conducted in 18.6%, 18.6%, 13.4%, and 16.9%, respectively, and pregnancy tests in 33.1% of visits. Presumptive gonorrhea and chlamydia treatment was provided in 53.7% and 52.2%, respectively, and emergency contraception in 27.2% of visits. Approximately 40% of patients were neither tested nor treated for either chlamydia or gonorrhea. Of patients with available laboratory test results, chlamydia, gonorrhea, and syphilis positivity rates were 10.0%, 3.8%, and 1.0%, respectively. AB - Low STI testing and treatment rates and high STI positivity identified in this study suggest that an important opportunity exists for improving STI screening and presumptive treatment for female patients presenting to the ED after SA. AB - Author manuscript AN - cdc:261889 C4 - PMC12244063 DO - https://doi.org/10.1111/acem.15058 IS - 3 J2 - Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine KW - Pregnancy KW - Adolescent KW - Female KW - Sex Offenses KW - Gonorrhea KW - Chlamydia Infections KW - Sexually Transmitted Diseases KW - Mass Screening KW - Humans KW - Young Adult KW - Emergency Service, Hospital KW - Adult KW - sexual assault KW - STI/HIV testing KW - presumptive STI treatment KW - STI positivity KW - emergency department KW - Humans KW - Female KW - Emergency Service, Hospital KW - Adult KW - Sexually Transmitted Diseases KW - Adolescent KW - Young Adult KW - Mass Screening KW - Sex Offenses KW - Gonorrhea KW - Chlamydia Infections KW - Pregnancy LA - eng PY - 2025 T2 - Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine T2 - Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine, 2025, v. 32, no. 3 TI - Low Sexually Transmitted Infection (STI) Screening and Presumptive Treatment and High STI Positivity Among United States Females Visiting the Emergency Department After Sexual Assault. VL - 32 UR - https://stacks.cdc.gov/view/cdc/261889 ER -
Three-dimensional Heat and Moisture Transfer Analysis For Thermal Protection of Firefighters' Gloves With Phase Change Materials.

Xu, Susan S. ;

Pollard, Jonisha

March 2025 | International Journal of Occupational Safety and Ergonomics : JOSE, 2025, v. 31, no. 1

Transient three-dimensional (3D) heat and moisture transfer simulations were conducted to analyze the thermal performances of the entire phase change material (PCM) integrated into firefighters' gloves. PCM was broken down into several segments to cover the back and palm of the hand but to avoid finger joints to keep hand functions. Parametric stud ...

10/09/2026

Supporting Files

Title : Three-dimensional Heat and Moisture Transfer Analysis For Thermal Protection of Firefighters' Gloves With Phase Change Materials. Personal Author(s) : Xu, Susan S.;Pollard, Jonisha;Zhao, Weihuan; Published Date : March 2025 Pages in Document : 214-230 (33 pdf pages) Source : International Journal of Occupational Safety and Ergonomics : JOSE, 2025, v. 31, no. 1 DOI : https://doi.org/10.1080/10803548.2024.2424043 Journal Title : International Journal of Occupational Safety and Ergonomics : JOSE
Xu, S. S., Pollard, J., & Zhao, W. (2025). Three-dimensional Heat and Moisture Transfer Analysis For Thermal Protection of Firefighters' Gloves With Phase Change Materials. International Journal of Occupational Safety and Ergonomics : JOSE, 31(1). https://doi.org/10.1080/10803548.2024.2424043

Xu, Susan S., Jonisha Pollard, and Weihuan Zhao. "Three-dimensional Heat and Moisture Transfer Analysis For Thermal Protection of Firefighters' Gloves With Phase Change Materials." International Journal of Occupational Safety and Ergonomics : JOSE 31, no. 1 (2025). https://doi.org/10.1080/10803548.2024.2424043.

Xu, Susan S., et al. "Three-dimensional Heat and Moisture Transfer Analysis For Thermal Protection of Firefighters' Gloves With Phase Change Materials." International Journal of Occupational Safety and Ergonomics : JOSE, vol. 31, no. 1, 2025. Stacks. https://doi.org/10.1080/10803548.2024.2424043.
Export RIS Citation Information. TY - Journal Article AU - Xu, Susan S. AU - Pollard, Jonisha AU - Zhao, Weihuan AB - Transient three-dimensional (3D) heat and moisture transfer simulations were conducted to analyze the thermal performances of the entire phase change material (PCM) integrated into firefighters' gloves. PCM was broken down into several segments to cover the back and palm of the hand but to avoid finger joints to keep hand functions. Parametric studies were performed to explore the effects of PCM melting temperatures, PCM locations in the glove and PCM layer thicknesses on the overall thermal performance improvement of firefighters' gloves. The study found that PCM segments could extend the time for hand skin surfaces (areas covered or not covered by PCM) to reach second-degree burn injury (60 °C) by 1.5-2 times compared to conventional firefighters' gloves without PCM. Moreover, PCM segments could help mitigate the temperature increase on hand skin and glove surface after fire exposure. AB - Author manuscript AN - cdc:261888 C4 - PMC11924176 DO - https://doi.org/10.1080/10803548.2024.2424043 IS - 1 J2 - International Journal of Occupational Safety and Ergonomics : JOSE KW - Hand KW - Burns KW - Hot Temperature KW - Equipment Design KW - Firefighters KW - Humans KW - Gloves, Protective KW - Materials Testing KW - Phase Transition KW - structural firefighters' gloves KW - thermal protective performance KW - 3D heat transfer modeling and simulations KW - novel material KW - Gloves, Protective KW - Humans KW - Firefighters KW - Hot Temperature KW - Burns KW - Equipment Design KW - Hand KW - Phase Transition KW - Materials Testing LA - eng PY - 2025 T2 - International Journal of Occupational Safety and Ergonomics : JOSE T2 - International Journal of Occupational Safety and Ergonomics : JOSE, 2025, v. 31, no. 1 TI - Three-dimensional Heat and Moisture Transfer Analysis For Thermal Protection of Firefighters' Gloves With Phase Change Materials. VL - 31 UR - https://stacks.cdc.gov/view/cdc/261888 ER -
Impact of Age of Sexual Debut on HIV Care Engagement Among Sexual and Gender Minorities in Nigeria.

Volpi, Connor ;

Adebiyi, Ruxton

March 2025 | Journal of Acquired Immune Deficiency Syndromes (1999), 2025, v. 98, no. 3

Sexual and gender minorities (SGM) bear a high burden of HIV. The age of anal sexual debut may influence HIV care engagement. Our objective was to evaluate this relationship to help health care providers promote and anticipate future HIV care engagement among at-risk SGM.The TRUST/RV368 study provided HIV testing and treatment at SGM-friendly clini ...

10/09/2026

Supporting Files

Title : Impact of Age of Sexual Debut on HIV Care Engagement Among Sexual and Gender Minorities in Nigeria. Personal Author(s) : Volpi, Connor;Adebiyi, Ruxton;Chama, John;Ononaku, Uche;Aka, Abayomi;Mitchell, Andrew;Shutt, Ashley;Kokogho, Afoke;Tiamiyu, Abdulwasiu B.;Baral, Stefan D.;Charurat, Man;Adebajo, Sylvia;Crowell, Trevor A.;Nowak, Rebecca G.; Published Date : March 2025 Pages in Document : 242-251 (20 pdf pages) Source : Journal of Acquired Immune Deficiency Syndromes (1999), 2025, v. 98, no. 3 DOI : https://doi.org/10.1097/QAI.0000000000003574 Journal Title : Journal of Acquired Immune Deficiency Syndromes (1999)
Volpi, C., Adebiyi, R., Chama, J., Ononaku, U., Aka, A., Mitchell, A., Shutt, A., Kokogho, A., Tiamiyu, A. B., Baral, S. D., Charurat, M., Adebajo, S., Crowell, T. A., & Nowak, R. G. (2025). Impact of Age of Sexual Debut on HIV Care Engagement Among Sexual and Gender Minorities in Nigeria. Journal of Acquired Immune Deficiency Syndromes (1999), 98(3). https://doi.org/10.1097/QAI.0000000000003574

Volpi, Connor, Ruxton Adebiyi, John Chama, Uche Ononaku, Abayomi Aka, Andrew Mitchell, and Ashley Shutt, et al.. "Impact of Age of Sexual Debut on HIV Care Engagement Among Sexual and Gender Minorities in Nigeria." Journal of Acquired Immune Deficiency Syndromes (1999) 98, no. 3 (2025). https://doi.org/10.1097/QAI.0000000000003574.

Volpi, Connor, et al. "Impact of Age of Sexual Debut on HIV Care Engagement Among Sexual and Gender Minorities in Nigeria." Journal of Acquired Immune Deficiency Syndromes (1999), vol. 98, no. 3, 2025. Stacks. https://doi.org/10.1097/QAI.0000000000003574.
Export RIS Citation Information. TY - Journal Article AU - Volpi, Connor AU - Adebiyi, Ruxton AU - Chama, John AU - Ononaku, Uche AU - Aka, Abayomi AU - Mitchell, Andrew AU - Shutt, Ashley AU - Kokogho, Afoke AU - Tiamiyu, Abdulwasiu B. AU - Baral, Stefan D. AU - Charurat, Man AU - Adebajo, Sylvia AU - Crowell, Trevor A. AU - Nowak, Rebecca G. AB - Sexual and gender minorities (SGM) bear a high burden of HIV. The age of anal sexual debut may influence HIV care engagement. Our objective was to evaluate this relationship to help health care providers promote and anticipate future HIV care engagement among at-risk SGM. AB - The TRUST/RV368 study provided HIV testing and treatment at SGM-friendly clinics in Abuja and Lagos, Nigeria. Self-reported age of sexual debut was dichotomized as <16 or ≥16 years. Multivariable logistic models estimated adjusted odds ratios (aOR) and 95% confidence intervals (CI) for the association of sexual debut with (1) HIV testing history, (2) HIV testing at the clinics, (3) initiation of antiretroviral therapy (ART) within 6 months of a clinic diagnosis, and (4) viral suppression within 12 months of ART initiation. AB - Of the 2680 participants, 30% (n = 805) reported a sexual debut <16 years. Those with an <16-year debut had significantly more receptive sex partners, condomless sex, and transactional sex (all P < 0.01) and were 24% less likely to have tested for HIV before enrollment (aOR: 0.76; CI: 0.62 to 0.93). However, <16-year debut was not associated with HIV testing, receiving ART, or achieving viral suppression once engaged with TRUST/RV368 (all P > 0.05). AB - SGM with <16-year debut engaged in behaviors that could increase HIV risk and were less likely to have a history of HIV testing. However, once enrolled in SGM-friendly clinics, uptake of HIV care was not associated with <16-year debut, suggesting that SGM-friendly care models may promote HIV care engagement. AB - Author manuscript AN - cdc:261887 C4 - PMC12284927 DO - https://doi.org/10.1097/QAI.0000000000003574 IS - 3 J2 - Journal of Acquired Immune Deficiency Syndromes (1999) KW - Adolescent KW - Age Factors KW - Female KW - Male KW - Humans KW - Middle Aged KW - Young Adult KW - Adult KW - Sexual and Gender Minorities KW - Sexual Behavior KW - HIV Infections KW - Patient Acceptance of Health Care KW - Humans KW - HIV Infections KW - Male KW - Female KW - Adult KW - Sexual Behavior KW - Young Adult KW - Adolescent KW - Sexual and Gender Minorities KW - Middle Aged KW - Age Factors KW - Patient Acceptance of Health Care LA - eng PY - 2025 T2 - Journal of Acquired Immune Deficiency Syndromes (1999) T2 - Journal of Acquired Immune Deficiency Syndromes (1999), 2025, v. 98, no. 3 TI - Impact of Age of Sexual Debut on HIV Care Engagement Among Sexual and Gender Minorities in Nigeria. VL - 98 UR - https://stacks.cdc.gov/view/cdc/261887 ER -

Previous Page Previous

361 - 380 / 1970

Next Page Next

Found an issue?

Send us an email at: publishinghd@cdc.gov